Nanobiotix SA
PAR:NANO

Watchlist Manager
Nanobiotix SA Logo
Nanobiotix SA
PAR:NANO
Watchlist
Price: 4.445 EUR -7.49% Market Closed
Market Cap: 209.5m EUR

Relative Value

There is not enough data to reliably calculate the relative value of NANO.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

NANO Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
64
Median 3Y
-15
Median 5Y
8.5
Industry
7.2
Forward
9.5
vs History
vs Industry
Median 3Y
-3.1
Median 5Y
-4.2
Industry
23.2
Forward
-4.6
vs History
vs Industry
Median 3Y
-7.3
Median 5Y
-8.1
Industry
19.3
vs History
vs Industry
Median 3Y
-6.4
Median 5Y
-7.4
Industry
22.5
vs History
vs Industry
Median 3Y
-4.2
Median 5Y
-3
Industry
2.7
vs History
vs Industry
57
Median 3Y
-14.6
Median 5Y
7.5
Industry
7.5
Forward
9.2
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
9.4
vs History
vs Industry
Median 3Y
-3.1
Median 5Y
-4.1
Industry
4.6
Forward
-4.8
vs History
vs Industry
Median 3Y
-3
Median 5Y
-4
Industry
4.5
Forward
-4.9
vs History
vs Industry
Median 3Y
-7.3
Median 5Y
-7.3
Industry
4.9
vs History
vs Industry
Median 3Y
-7.2
Median 5Y
-7.2
Industry
3.7
vs History
47
vs Industry
2
Median 3Y
9.6
Median 5Y
11.6
Industry
4.9

Multiples Across Competitors

NANO Competitors Multiples
Nanobiotix SA Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
FR
Nanobiotix SA
PAR:NANO
210.7m EUR -18.2 -3.1 -3.1 -3
FR
Pharnext SCA
OTC:PNEXF
6T USD 34 361 436.7 -163 314.8 -198 316.3 -196 053.2
US
Abbvie Inc
NYSE:ABBV
337.9B USD 5.9 81 15.5 22.8
US
Amgen Inc
NASDAQ:AMGN
160.3B USD 4.7 26.9 14.5 23.9
US
Gilead Sciences Inc
NASDAQ:GILD
138.2B USD 4.8 23 10.1 13.9
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
117B USD 10.5 -118 25.2 26.4
US
Epizyme Inc
F:EPE
94.1B EUR 2 050.2 -523.2 -569.7 -554.5
AU
CSL Ltd
ASX:CSL
115.8B AUD 4.9 27.3 16.9 21.1
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
57.9B USD 4.1 12.8 11.5 12.9
US
Seagen Inc
F:SGT
39.3B EUR 19.7 -60.6 -65.3 -58.9
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
39.8B USD 17 -147.6 -661.3 -331.4
P/S Multiple
Revenue Growth P/S to Growth
FR
Nanobiotix SA
PAR:NANO
Average P/S: 3 436 355.8
Negative Multiple: -18.2
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
34 361 436.7
N/A N/A
US
Abbvie Inc
NYSE:ABBV
5.9
8%
0.7
US
Amgen Inc
NASDAQ:AMGN
4.7
4%
1.2
US
Gilead Sciences Inc
NASDAQ:GILD
4.8
3%
1.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
10.5
10%
1.1
US
E
Epizyme Inc
F:EPE
2 050.2
N/A N/A
AU
CSL Ltd
ASX:CSL
4.9
7%
0.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
4.1
4%
1
US
S
Seagen Inc
F:SGT
19.7
30%
0.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
17
29%
0.6
P/E Multiple
Earnings Growth PEG
FR
Nanobiotix SA
PAR:NANO
Average P/E: 34.2
Negative Multiple: -3.1
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -163 314.8 N/A N/A
US
Abbvie Inc
NYSE:ABBV
81
88%
0.9
US
Amgen Inc
NASDAQ:AMGN
26.9
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
23
188%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -118 N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -523.2 N/A N/A
AU
CSL Ltd
ASX:CSL
27.3
16%
1.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
12.8
7%
1.8
US
S
Seagen Inc
F:SGT
Negative Multiple: -60.6 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -147.6 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
FR
Nanobiotix SA
PAR:NANO
Average EV/EBITDA: 15.6
Negative Multiple: -3.1
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -198 316.3 N/A N/A
US
Abbvie Inc
NYSE:ABBV
15.5
13%
1.2
US
Amgen Inc
NASDAQ:AMGN
14.5
17%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
10.1
6%
1.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.2
17%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -569.7 N/A N/A
AU
CSL Ltd
ASX:CSL
16.9
11%
1.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
11.5
11%
1
US
S
Seagen Inc
F:SGT
Negative Multiple: -65.3 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -661.3 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
FR
Nanobiotix SA
PAR:NANO
Average EV/EBIT: 20.2
Negative Multiple: -3
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -196 053.2 N/A N/A
US
Abbvie Inc
NYSE:ABBV
22.8
29%
0.8
US
Amgen Inc
NASDAQ:AMGN
23.9
32%
0.7
US
Gilead Sciences Inc
NASDAQ:GILD
13.9
11%
1.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26.4
17%
1.6
US
E
Epizyme Inc
F:EPE
Negative Multiple: -554.5 N/A N/A
AU
CSL Ltd
ASX:CSL
21.1
14%
1.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
12.9
11%
1.2
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.9 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -331.4 N/A N/A